{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:14:27Z","timestamp":1783314867004,"version":"3.54.6"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017961","name":"Health Commission of Heilongjiang Province","doi-asserted-by":"publisher","award":["ZL2025H002"],"award-info":[{"award-number":["ZL2025H002"]}],"id":[{"id":"10.13039\/100017961","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Adenoid cystic carcinoma is a rare salivary gland malignancy of the head and neck region characterized by perineural invasion, distant metastasis, and a lack of effective targeted therapies. The molecular mechanisms underlying its progression remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we identified the cystic fibrosis transmembrane conductance regulator (CFTR) as a consistently downregulated gene in adenoid cystic carcinoma through differential expression analysis of multiple independent transcriptomic cohorts. Functional experiments were performed in SACC-83 and SACC-LM cell lines, including ectopic expression and knockdown of CFTR, RNA sequencing, quantitative polymerase chain reaction, and Western blot analyses. Pharmacological inhibition of Hsp70 using VER155008 and activation of the heat shock response by HSF1A were also assessed for effects on cell viability, migration, invasion, and apoptosis. Subcutaneous xenograft experiments in nude mice were conducted to evaluate tumor growth following stable CFTR knockdown in SACC-LM cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Preliminary Kaplan-Meier survival analysis demonstrated that low CFTR expression was significantly associated with inferior overall survival, although this finding requires validation in a larger independent cohort. Protein interaction network modeling revealed that CFTR occupies a hub position within a conserved interaction network linking ion channel regulation, protein quality control, and kinase signaling. Functional experiments showed that ectopic expression of CFTR suppressed cell proliferation, migration, and invasion, whereas CFTR knockdown enhanced these malignant phenotypes, supporting a tumor-suppressive role for CFTR in these model systems. RNA sequencing of CFTR-overexpressing cells revealed coordinated downregulation of heat shock protein family members, including HSPA1A, HSPA1B, and HSPA6, with enrichment of pathways related to protein refolding. Quantitative polymerase chain reaction and Western blot analyses confirmed that CFTR expression is inversely associated with Hsp70 family members and MAPK1 (ERK2) at both mRNA and protein levels. Pharmacological inhibition of Hsp70 using VER155008 suppressed cell viability, migration, and invasion in a dose-dependent manner and induced apoptosis, phenocopying the effects of CFTR restoration. Subcutaneous xenograft experiments in nude mice further demonstrated that stable CFTR knockdown in SACC-LM cells markedly accelerated tumor growth. Conversely, activation of the heat shock response by HSF1A promoted proliferation, migration, and invasion, recapitulating the consequences of CFTR loss. Notably, Hsp70 inhibition was accompanied by compensatory upregulation of MAPK1 transcripts, suggesting that CFTR is inversely associated with Hsp70 and MAPK1 through parallel rather than linear mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings indicate that CFTR silencing in adenoid cystic carcinoma is accompanied by elevated Hsp70 chaperone expression, and that pharmacological targeting of Hsp70 phenocopies, rather than necessarily mediates, the tumor-suppressive effects of CFTR restoration in the SACC-83 and SACC-LM lineage. Targeting Hsp70 therefore provides a preclinical rationale, rather than direct translational evidence, for further investigation in this otherwise treatment-refractory malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1836263","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:15Z","timestamp":1783311675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CFTR functions as a tumor suppressor in adenoid cystic carcinoma and its silencing reveals an associated vulnerability involving the Hsp70 chaperone system"],"prefix":"10.3389","volume":"16","author":[{"given":"Gang","family":"Zhao","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Jiamusi University","place":["Jiamusi, China"]},{"name":"Stomatology College of Jiamusi University","place":["Jiamusi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Li","sequence":"additional","affiliation":[{"name":"Stomatology College of Jiamusi University","place":["Jiamusi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Stomatology College of Jiamusi University","place":["Jiamusi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Su","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Jiamusi University","place":["Jiamusi, China"]},{"name":"Stomatology College of Jiamusi University","place":["Jiamusi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck--an update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23925","article-title":"Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials","volume":"38","author":"Dillon","year":"2016","journal-title":"Head Neck"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02795-4","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade","volume":"131","author":"Zhou","year":"2024","journal-title":"Br J Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2643","article-title":"The mutational landscape of adenoid cystic carcinoma","volume":"45","author":"Ho","year":"2013","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw376.04","article-title":"Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies","volume":"28","author":"Ross","year":"2017","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1183\/2312508x.10016616","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet (London England)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i3.282","article-title":"Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers","volume":"8","author":"Hou","year":"2016","journal-title":"World J Gastrointestinal Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2755-6","article-title":"Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer","volume":"75","author":"Zhang","year":"2018","journal-title":"Cell Mol Life Sciences: CMLS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Institute"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.3c00310","article-title":"CFTR folding: from structure and proteostasis to cystic fibrosis personalized medicine","volume":"18","author":"McDonald","year":"2023","journal-title":"ACS Chem Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01897","article-title":"Proteostasis regulators in cystic fibrosis: current development and future perspectives","volume":"65","author":"Brusa","year":"2022","journal-title":"J Med Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.05.039","article-title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways","volume":"158","author":"Taipale","year":"2014","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.864426","article-title":"Endoplasmic reticulum stress and the unfolded protein response in cerebral ischemia\/reperfusion injury","volume":"16","author":"Wang","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00761-8","article-title":"PKA compartmentalization links cAMP signaling and autophagy","volume":"28","author":"Grisan","year":"2021","journal-title":"Cell Death Differ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/path.6172","article-title":"Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers","volume":"261","author":"Persson","year":"2023","journal-title":"J Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/hed.28123","article-title":"Alternative MYB promoter activity is a potential prognostic biomarker in head and neck adenoid cystic carcinoma","volume":"47","author":"J\u00e4wert","year":"2025","journal-title":"Head Neck"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s41598-023-28901-9","article-title":"Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways","volume":"13","author":"Romani","year":"2023","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti525","article-title":"BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis","volume":"21","author":"Durinck","year":"2005","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8.13.1","DOI":"10.1002\/0471250953.bi0813s47","article-title":"Biological network exploration with Cytoscape 3","volume":"47","author":"Su","year":"2014","journal-title":"Curr Protoc Bioinf"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.07.021","article-title":"Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer","volume":"1833","author":"Zhang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.043","article-title":"Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2686","article-title":"The unfolded protein response in health and disease","volume":"11","author":"Austin","year":"2009","journal-title":"Antioxid Redox Signaling"},{"key":"B28","article-title":"HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview","volume":"32","author":"Rappa","year":"2012","journal-title":"Anticancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1388999","article-title":"Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target","volume":"14","author":"Hu","year":"2024","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1587414","article-title":"The dual-function of HSP70 in immune response and tumor immunity: from molecular regulation to therapeutic innovations","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11410","DOI":"10.1038\/s41598-017-11764-2","article-title":"A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1836263\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:16Z","timestamp":1783311676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1836263\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":31,"alternative-id":["10.3389\/fonc.2026.1836263"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1836263","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1836263"}}